Compare AbCellera Biologics Inc (ABCL) vs Dover Corp (DOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Dover Corp — how do they compare? AbCellera Biologics Inc trades at $9.1 (market cap $2.99B), while Dover Corp trades at $208.79 (market cap $28.07B). The key difference: Dover Corp is far larger — about 9.4× AbCellera Biologics Inc's market cap, and Dover Corp pays a 1.01% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | DOV | |
|---|---|---|
Market Cap | $2.99B | $28.07B |
Sector | Health | Industrials |
52-Week High | $9.76 | $233.31 |
52-Week Low | $2.78 | $161.16 |
Enterprise Value | $2.58B | $29.58B |
Dividend Yield | — | 1.01% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Dover Corp
Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →
